Harvoni Cancer Lawsuit

Harvoni Cancer Lawsuit

Harvoni is a treatment option available to treat advanced cancers. It is not appropriate for patients suffering from pancreatic cancer, small cell carcinoma or cervical cancer. The Food and Drug Administration has approved it for the treatment of pancreatic cancer, but it is not suitable for patients with other types of cancers, nor recommended for advanced cancers. Yet, the manufacturer continues to sell it as part of its treatment program for patients diagnosed with advanced pancreatic cancer.

There are two lawsuits filed against Harvoni. One suit was filed by a patient in California.

The suit names the company under the Class Action Law; it is named “Monsanto Co.”; and it is seeking compensatory and/or punitive damages for personal injury, negligence and wrongful death. The second lawsuit, which was filed in New Jersey, names the company under the Tort Claims Act. It is named “EA Bio-Tech Ltd.” and is seeking compensatory and/or punitive damages for various injuries, including wrongful death.

The FDA has placed a black box warning on the product, stating that there is not sufficient evidence to support the claims that Harvoni treats any disease.

However, the manufacturer has a record of selling Harvoni in the past, and customers have purchased it from that company. Some of the customers had severe reactions. One man died from stomach pains. Another suffered from diarrhea, vomiting and heartburn. Several others had nausea, vomiting and an upset stomach.

Even if adverse reactions were identified with Harvoni, it is unlikely that they caused the death of the patient.

In most cases, patients are given the product without incident. In one case, a patient developed vaginal bleeding that required emergency treatment. There have been no reports of adverse reactions to this drug. In another case, the urine tested positive for melatonin, which is manufactured by the same company.

The manufacturers of Harvoni admit that the company holds all rights to the formulation of the drug, but they assert that it is safe for use even though their own studies show that there may be some negative reactions.

In addition, there are several people who have filed Harvoni lawsuits against GlaxoSmithKline (GlaxoSmithKline is also the manufacturer of Accutane). GlaxoSmithKline has acknowledged liability and paid several settlements to victims of the supplement. If victims win their lawsuit against GlaxoSmithKline, the company could be forced to change the formula of its famous weight loss drug.

The FDA is still investigating whether or not it is responsible for the death of the man who became terminally ill from taking Harvoni. This lawsuit may make that investigation much easier to answer. While the lawsuit is moving through the courts, patients who have been diagnosed with the condition can begin using the weight-loss treatment. As is clear, this is a complicated lawsuit that will continue to unfold in the coming months.

Leave a Reply

Your email address will not be published. Required fields are marked *